Search clinical trials for: PD 0332334

Total 1152 results

Pfizer

Completed

An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers

Generalized Anxiety Disorder

United States
Pfizer

Terminated

A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.

Renal Insufficiency | Pharmacokinetics

United States
Pfizer

Terminated

A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder

United States
Pfizer

Completed

A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis

Pharmacokinetics | Renal Dialysis

United States
Pfizer

Withdrawn

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder

United States
Pfizer

Completed

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Pfizer

Terminated

Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time

Generalized Anxiety Disorder

Singapore
Pfizer

Withdrawn

A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects

Generalized Anxiety Disease
Pfizer

Completed

A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder
Pfizer

Terminated

Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body

Generalized Anxiety Disorder

United States
Yale University
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's Disease

Parkinson Disease

United States
Lars Møller Pedersen

Completed

Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma

Follicular Lymphoma

Denmark
Peking University First Hospital

Terminated

Intensive Versus Regular Dosage For PD In AKI.

Peritoneal Dialysis | Acute Kidney Injury

China
Pfizer

Terminated

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

Generalized Anxiety Disorder

United States, Korea, Republic of, Italy, Hungary, Russian Federation
Pfizer

Completed

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Interstitial Cystitis | Painful Bladder Syndrome

Canada, United States, France, Denmark, Finland, Germany
Shanghai Zhongshan Hospital

Recruiting

Gut Microbiota and Cancer Immunotherapy Response

Non-Small Cell Lung Cancer

China
Pfizer

Terminated

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

Generalized Anxiety Disorder

United States, Taiwan, Russian Federation, Hungary
The University of Queensland
The HOME Network; Australia and New Zealand Dialysis and Transplant Registry; New Zealand Peritoneal Dialysis Registry

Recruiting

Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial (TEACH-PD)

Kidney Disease, Chronic | Peritoneal Dialysis Catheter Exit Site Infection | Peritoneal Dialysis Catheter-Associated Peritonitis | Peritoneal Dialysis Catheter Tunnel Infection

Australia, New Zealand
Pfizer

Terminated

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

Generalized Anxiety Disorder

United States, Hungary
Tongji Hospital
National Natural Science Foundation of China

Recruiting

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study (NICCE)

Esophageal Squamous Cell Carcinoma | Neoadjuvant Therapies

China
Centre Leon Berard
NETRIS Pharma

Recruiting

NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies (IMMUNONET)

Advanced Solid Tumors | Metastatic Solid Tumors

France
University of Calgary
McGill University; University of Ottawa; Queen's University; Halton Health (Oakville) and other collaborators

Recruiting

Guidewire Management in ERCP

ERCP

Canada
Thomas Marron

Recruiting

Dupilumab_Metastatic NSCLC

Metastatic Non-small Cell Lung Cancer

United States
KU Leuven

Recruiting

POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

Achalasia

Belgium
AWAK Technologies Pte Ltd
Singapore General Hospital

Active, not recruiting

Late Feasibility Study to Evaluate Safety and Efficacy of AWAK PD Device in Subjects With ESKD.

Chronic Kidney Diseases

Singapore
Flint Rehabilitation Devices, LLC
University of Southern California

Completed

FitMi PD Home Therapy for Parkinson's Disease

Parkinson Disease

United States
University of Colorado, Boulder
National Institute of Mental Health (NIMH); Emory University; Kaiser Permanente

Completed

The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression

Depression | Postpartum Depression | Pregnancy

United States
Schiffler Cancer Center

Completed

Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial

Prostatic Neoplasm

United States
Institut Paoli-Calmettes

Completed

The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula (NLR)

Pancreas Neoplasm
University of Alabama at Birmingham

Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 (MEK Inhibitor)

Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN

United States
Pfizer

Terminated

MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Pfizer

Completed

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

Irritable Bowel Syndrome
Rigshospitalet, Denmark
Novo Nordisk A/S

Completed

Prospective Prevalence and Validation Study of Pediatric Intensive Care Delirium.

Pediatric Delirium

Denmark
University of Chicago

Completed

DBS Frequency on Swallowing Function in Parkinson's Disease

Parkinson's Disease

United States
Sharp HealthCare

No longer available

A Single Patient IND for PD-0325901

Prior Treatment With PD-0325901 With Ongoing Clinical Response

United States
Pfizer

Completed

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

Hot Flashes

United States, France, Spain, Australia, South Africa, Canada
SpringWorks Therapeutics, Inc.

Active, not recruiting

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (ReNeu)

Plexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)

United States
Zhongnan Hospital

Recruiting

Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Louisiana State University Health Sciences Center...

Completed

Designer Dialysis Peritoneal Dialysis

Quality of Life | Peritoneal Dialysis
photonamic GmbH & Co. KG

Terminated

Fluorescence-guided Resection in Breast Cancer

Breast Tumour

Germany
University of Chile
Comisión Nacional de Investigación Científica y Tecnológica

Unknown

Physical Activity Enhancement Using Pedometers in COPD

COPD

Chile
Pfizer

Completed

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

Primary Insomnia

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

Lung Cancer

China
Hoffmann-La Roche

Completed

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Carcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell

United Kingdom, Czechia, Germany, Poland, Spain, Switzerland
St. Jude Children's Research Hospital
SpringWorks Therapeutics, Inc.

Recruiting

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Low-Grade Glioma | Recurrent Low-Grade Glioma | Progressive Low-Grade Glioma

United States
Fresenius Medical Care Deutschland GmbH
Winicker Norimed GmbH; James Motta, Clinical Research Associate (CRA)

Completed

Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers

Renal Failure | End Stage Renal Disease

Chile
University of Colorado, Boulder
National Institute of Mental Health (NIMH); Emory University; Kaiser Permanente

Completed

Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence

Depression | Postpartum Depression | Pregnancy

United States
Baodong Qin

Unknown

Effect of Chemotherapy on PD-L1 in NSCLC

Chemotherapy | Immunotherapy | PD-L1

China
Tatarstan Cancer Center

Unknown

Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer

Hereditary Breast Cancer

Russian Federation
Innovative Diagnostics Inc

Terminated

Rapid Point-of-Care Salivary Diagnostic for Periodontal Health

Gingivitis | Periodontal Disease

United States

Search clinical trials for: PD 0332334

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations